Dear members,

This week pharmaphorum features the second part of Allan Showalter’s two part piece on patient compliance, or noncompliance as the issue is more appropriately defined! Here, he expands on the some of the key factors around compliance to challenge the way we look at it, which is perhaps the first step to finding more effective solutions. Also new on the site on Friday was the latest “What Are IDEAs Made Of”, or WAIMO, piece which this week looks at forward planning in late-stage clinical trials. Are we in such a rush to get the drug to market that we sometimes don’t stop to think about the right trial design?

Recent forum posts:

Comments continue to come in on some of the popular topics:

Launch indicators
http://www.pharmapho...ic/launch-indicators

Trends in R&D investment
http://www.pharmapho...nds-in-rd-investment

What is the ideal market access scheme?
http://www.pharmapho...market-access-scheme

If you want to know how to register and place comments then click here:

http://www.pharmapho...comments-on-the-site

Recent articles:

Published by Allan Showalter, MD (AlignMap) on Tuesday 20th April
“Rethinking patient noncompliance (Part 2)”
Following on from the first article, part 2 of this series sees Allan Showalter exploring some possible solutions to addressing the issues of patient noncompliance.
http://www.pharmapho...oncompliance-part-2/

Published by Mike Rea (IDEA Pharma) on Friday 16th April
“What Are IDEAs Made Of: Thinking ahead”
Does it feel like you never have enough time to properly plan ahead with drug development? In this week’s WAIMO Mike Rea suspects you’re not the only one.
http://www.pharmapho...e-of-thinking-ahead/

It’s good to see some of the regular faces already commenting on these pieces, so please come and join them and share your opinion.

Other updates:

A whole raft of new events by Management Forum have been added to the site, including:

An Essential Guide to Clinical Trial Regulations
http://www.pharmapho...l_trial_regulations/

European Marketing Codes and Compliance
http://www.pharmapho...odes_and_compliance/

Latest Developments in GCP
http://www.pharmapho...developments_in_gcp/

Pharmacoepidemiology
http://www.pharmapho...harmacoepidemiology/

And finally...as the skies finally open over Europe it’s interesting to see social media play such a key role in keeping people talking and getting them home!

Have a great week,

Paul.